|
n Commission granted a marketing authorisation valid throughout the EU for Exforge to Novartis Europharm Limited on 17 January 2007.
↑ back to table of contents ↑
Name
Exforge 5 mg/160 mg film-coated tablets
Composition
Each film-coated tablet contains 5 mg of amlodipine (as amlodipine besylate) and 160 mg of valsartan.
For a full list of excipients, see section 6.1.
Pharmaceutical Form
Film-coated tablet
Dark yellow, oval film-coated tablet, imprinted with “NVR” on one side and “ECE” on the other side.
Are you an Healthcare Professional? Access professional drug leaflets on Diagnosia.com!
|
